Advertisement
Research Article Free access | 10.1172/JCI104163
Infectious Disease Laboratory, Second (Cornell) Medical Division, Bellevue Hospital, New York
National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Department of Pathology, The New York Hospital-Cornell Medical Center, New York, N. Y.
*This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases, Bethesda, Md. (E-2659), the Charles Pfizer Co., Inc., New York. The Health Research Council of New York City. The New York Trudeau Society, and Training Grant E-6 from the National Institute of Allergy and Infectious Diseases. A preliminary report of these studies was presented to the Second Conference on Medical Mycology held under the auspices of The New York Academy of Sciences, January 11 and 12, 1960.
Find articles by Louria, D. in: PubMed | Google Scholar
Infectious Disease Laboratory, Second (Cornell) Medical Division, Bellevue Hospital, New York
National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Department of Pathology, The New York Hospital-Cornell Medical Center, New York, N. Y.
*This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases, Bethesda, Md. (E-2659), the Charles Pfizer Co., Inc., New York. The Health Research Council of New York City. The New York Trudeau Society, and Training Grant E-6 from the National Institute of Allergy and Infectious Diseases. A preliminary report of these studies was presented to the Second Conference on Medical Mycology held under the auspices of The New York Academy of Sciences, January 11 and 12, 1960.
Find articles by Fallon, N. in: PubMed | Google Scholar
Infectious Disease Laboratory, Second (Cornell) Medical Division, Bellevue Hospital, New York
National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Department of Pathology, The New York Hospital-Cornell Medical Center, New York, N. Y.
*This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases, Bethesda, Md. (E-2659), the Charles Pfizer Co., Inc., New York. The Health Research Council of New York City. The New York Trudeau Society, and Training Grant E-6 from the National Institute of Allergy and Infectious Diseases. A preliminary report of these studies was presented to the Second Conference on Medical Mycology held under the auspices of The New York Academy of Sciences, January 11 and 12, 1960.
Find articles by Browne, H. in: PubMed | Google Scholar
Published September 1, 1960 - More info